Endovascular Therapy Following Imaging Evaluation for Ischemic Stroke 3

A trial with no phase registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 182 participants.

Also called NCT02586415

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 182 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02586415
Other papers using this trial's data
  • Association of Thrombectomy With Stroke Outcomes Among Patient Subgroups: Secondary Analyses of the DEFUSE 3 Randomized Clinical Trial JAMA neurology, 2019-04-01 DOI, PubMed 30688974, PMC6459134 Not in the PMC Open Access subset.
  • Clinical Outcomes and Identification of Patients With Persistent Penumbral Profiles Beyond 24 Hours From Last Known Well: Analysis From DEFUSE 3 Stroke, 2021-03 DOI, PubMed 33563012
  • Endovascular Treatment in the DEFUSE 3 Study Stroke, 2018-08 DOI, PubMed 29986935, PMC6202142 In the PMC Open Access subset under a licence that is not Creative Commons.
  • Ischemic Core and Hypoperfusion Volumes Correlate With Infarct Size 24 Hours After Randomization in DEFUSE 3 Stroke, 2019-03 DOI, PubMed 30727840
  • Quality of Life in Physical, Social, and Cognitive Domains Improves With Endovascular Therapy in the DEFUSE 3 Trial Stroke, 2021-04 DOI, PubMed 33596675, PMC7987886 In the PMC Open Access subset under a licence that is not Creative Commons.
  • Rapid Neurologic Improvement Predicts Favorable Outcome 90 Days After Thrombectomy in the DEFUSE 3 Study Stroke, 2019-05 DOI, PubMed 30932783, PMC6476661 In the PMC Open Access subset under a licence that is not Creative Commons.
  • Renal Safety of Multimodal Brain Imaging Followed by Endovascular Therapy Stroke, 2021-01 DOI, PubMed 33250038, PMC9135171 In the PMC Open Access subset under a licence that is not Creative Commons.
  • Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging The New England journal of medicine, 2018-02-22 DOI, PubMed 29364767, PMC6590673 In the PMC Open Access subset under a licence that is not Creative Commons.
  • What predicts poor outcome after successful thrombectomy in late time windows? Journal of neurointerventional surgery, 2021-05 DOI, PubMed 32554693

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Terminated (from the registry)

Technical summary

Registry record NCT02586415. Randomized; no masking; primary purpose treatment. Start 2016-04 (registry gives no type); primary completion 2017-08-23 (actual). Results posted on 2018-09-19.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Endovascular Therapy Following Imaging Evaluation for Ischemic Stroke 3
Acronym
DEFUSE 3
Condition
Stroke, Acute
Condition
Cerebral Infarction
Intervention (Procedure)
Endovascular Thrombectomy
Intervention (Device)
Trevo Retriever
Intervention (Device)
Solitaire™ FR Revascularization Device
Intervention (Device)
Penumbra thrombectomy system
Intervention (Device)
Covidien MindFrame Capture Revascularization Device
Lead sponsor
Gregory W Albers (class: other)
Collaborator
National Institute of Neurological Disorders and Stroke (NINDS) (class: US National Institutes of Health)
Collaborator
University of Cincinnati (class: other)
Collaborator
Medical University of South Carolina (class: other)
Collaborator
NINDS Stroke Trials Network (StrokeNet) (class: other)

Record details

Record id
cardio:ct-nct02586415
Content hash
59984628c64d008ab9cef0edb4af66824b8cdfa576f2fa2612e4c40ae39b4abb